EDSAEdesa Biotech, Inc.
4.430USDMkt Cap: 42.71M $P/E: —3d ago
Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. It dev…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap42.71M $
Enterprise Value40.79M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-7.19M $
Revenue/Share—
Last Price4.430 USD
Fiscal Year EndSep 2025
MR QuarterJun 2026
Employees17
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.30
PEG—
EV/EBITDA-2.81
EV/Revenue—
P/S—
P/B108.05
EPS (TTM)-1.72
EPS (Forward)—
52W Range
4.20031% of range4.950
52W High4.950 USD
52W Low4.200 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-57.71%
ROA-53.11%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.32M $
CapEx (TTM)—
FCF Margin—
FCF Yield-9.40%
Net Debt-10.33M $
Net Debt/EBITDA0.71
Balance Sheet
Debt/Equity0.00
Current Ratio2.76
Quick Ratio2.70
Book Value/Sh0.0410 USD
Cash/Share1.072 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJun 10, 2019
Splits
Last Split1:7
Split DateOct 11, 2023
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)16.33 USD
Upside (mean)+268.7%
Target Range9.000 USD – 21.00 USD
$9.000+268.7% to mean$21.00
# Analysts3
Ownership
Shares Out.9.64M
Float5.58M
Insiders13.38%
Institutions32.25%
Short Interest
Short Ratio3.1d
Short % Float2.42%
Short % Out.2.25%
Shares Short216.39K
Short (prev mo.)283.23K
Technical
SMA 506.206 (-28.6%)
SMA 2005.133 (-13.7%)
Beta1.08
S&P 52W Chg19.18%
Avg Vol (30d)156.13K
Avg Vol (10d)101.83K
Technical Indicators
RSI (14)33.0
MACD-0.3316
MACD Signal-0.3475
MACD Hist.+0.0159
BB Upper5.883 USD
BB Middle5.263 USD
BB Lower4.643 USD
BB Width23.57%
ATR (14)0.6912 USD
Vol Ratio (20d)2.03x